Hydrochlorothiazide/Methyldopa

氢氯噻嗪/甲基多巴

Report date: 2022/01/14 13:23:58

Base Information

Drug NameHydrochlorothiazide/Methyldopa
Drug Alias Name甲基多巴/氢氯噻嗪Hydrochlorothiazide and MethyldopaMethyldopa - hydrochlorothiazide mixt甲基多巴氢氯噻嗪Methyldopa and hydrochlorothiazide +[7] 
ClassificationSmall molecules
Mechanisms of ActionAdrenergic receptors alpha-2 agonistsThiazide-sensitive sodium-chloride cotransporter inhibitors
TargetsThiazide-sensitive sodium-chloride cotransporterAdrenergic receptors alpha-2
Therapy Area/IndicationsHypertension
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryN/A
CombinationsYes HydrochlorothiazideMethyldopa
Global Highest StatusApproved
Highest Status in ChinaN/A
Originator CompaniesMerck Sharp & Dohme Corp
China Registration ClassN/A

Develop Information

Active CompaniesMerck Sharp & Dohme Corp
Inactive CompaniesN/A
Active IndicationsHypertension
Inactive IndicationsN/A

Other Information

ATC CodeC02LB01C03AX01
Related LinksKEGG